Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 7/20 | 0.60 |
| ▸ | PIM3 | Q86V86 | 7/20 | 0.60 |
| ▸ | CSNK2A2 | P19784 | 6/20 | 0.60 |
| ▸ | CSNK2B | P67870 | 6/20 | 0.60 |
| ▸ | PIM2 | Q9P1W9 | 6/20 | 0.60 |
| ▸ | TNKS2 | Q9H2K2 | 6/20 | 0.60 |
| ▸ | TNKS | O95271 | 5/20 | 0.60 |
| ▸ | WNT3A | P56704 | 3/20 | 0.60 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.58 |
| ▸ | PARP1 | P09874 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.50 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.50 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6858209 | 0.81 | TNKS2 (0.54) | PIM1PIM3CSNK2A2CSNK2BPIM2 | |
| SCHEMBL2220413 | 0.78 | PIM1 (0.55) | PIM1PIM3CSNK2A2CSNK2BPIM2 | |
| SCHEMBL914340 | 0.78 | MEN1 (0.53) | PIM1PIM3CSNK2A2CSNK2BPIM2 | |
| SCHEMBL1852290 | 0.77 | TNKS (0.63) | PIM1PIM3CSNK2A2CSNK2BPIM2 | |
| SCHEMBL12439433 | 0.77 | ALDH1A1 (0.57) | PIM1PIM3CSNK2A2CSNK2BPIM2 | |
| SCHEMBL1853864 | 0.75 | PIM1 (1.00) | PIM1PIM3CSNK2A2CSNK2BPIM2 | |
| SCHEMBL11284110 | 0.75 | TNKS (1.00) | TNKS2TNKSWNT3APARP2PARP1 | |
| SCHEMBL7568265 | 0.73 | TNKS (1.00) | TNKS2TNKSWNT3APARP2PARP1 | |
| SCHEMBL15775279 | 0.73 | TNKS (1.00) | TNKS2TNKSWNT3APARP2PARP1 | |
| SCHEMBL2217397 | 0.72 | SMN1; SMN2 (0.47) | PIM1PIM3CSNK2A2CSNK2BPIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110178107-A1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2011-07-21 | — | — | US | disclosed |
| US-20110178107-A1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2011-07-21 | — | — | US | disclosed |
| US-20110178107-A1 | HCV PROTEASE INHIBITORS | TAIGEN BIOTECHNOLOGY CO., LTD. (TW) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178107-A1 | HCV PROTEASE INHIBITORS | HAVCR2, RNASE1, SERPINB1 | PIM1 2408/4885PIM3 2176/4885CSNK2A2 2352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.